Elastagen Completes A$13m Series B Equity Financing

Elastagen Completes A$13m Series B Equity Financing January 2016, Sydney: Elastagen Pty Ltd, a clinical stage medical company developing products based on a proprietary recombinant human tropoelastin platform technology, announces the closing of a A$13 million Series B financing round. The financing included new investors Korea Investment Partners (KIP), AMOREPACIFIC Ventures, and the Wellcome Trust.…

Details